Skip to main content
. 2022 Jul 28;16:910574. doi: 10.3389/fnins.2022.910574

TABLE 3.

Other secondary outcomes.

Outcome measuresa CX-DZ-II (n = 83) SDZ-II (n = 80) p value
Overall responders, n (%) 41 (49.40) 41 (51.25) 0.869
Drug-usage rate of NSAAs, n (%) 0 (100) 0 (100) 1.000
Defect rate of the instrument, n (%) 6 (7.23) 3 (3.75) 0.496
Excellent rate of instrument, n (%)
Score < 16 82 (98.80) 79 (98.75) 1.000
Score > 16 1 (1.20) 1 (1.25)

aStatistical analysis set was based on the intention-to-treat population.